Recent studies have found that sinensetin can attenuate interleukin-1β-induced cartilage damage ameliorate osteoarthritis by regulating expression of serpin family A member 3, and possesses strong anticancer activities and a wide range of pharmacological (anti-inflammatory, anti-obesity, anti-dementia, vasorelaxant) activities. The gene discussed is SERPINA3; the disease is Obesity.